Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:32 pm Purchase | 13G | Kiniksa Pharmaceuticals International plc KNSA | HHLR ADVISORS LTD. | 1,582,635 3.900% | 1,582,635 (New Position) | View |
| 2024-11-14 4:15 pm Purchase | 13G | Kiniksa Pharmaceuticals International plc KNSA | Fairmount Funds Management LLC | 3,204,841 7.900% | 3,204,841 (New Position) | View |
| 2024-11-13 4:30 pm Purchase | 13G | Kiniksa Pharmaceuticals International plc KNSA | Rubric Capital Management LP | 2,419,103 5.960% | 2,419,103 (New Position) | View |
| 2024-11-08 5:31 pm Unchanged | 13G | Kiniksa Pharmaceuticals International plc KNSA | BlackRock Inc. | 3,815,656 9.400% | 0 (Unchanged) | View |
| 2024-10-21 4:11 pm Purchase | 13G | Kiniksa Pharmaceuticals International plc KNSA | BlackRock Inc. | 3,815,656 9.400% | 3,815,656 (New Position) | View |
| 2024-10-08 5:29 pm Purchase | 13D | Kiniksa Pharmaceuticals International plc KNSA | BAKER BROS. ADVISORS LP | 3,151,029 7.700% | 3,151,029 (New Position) | View |
| 2024-04-05 12:21 pm Purchase | 13G | Kiniksa Pharmaceuticals International plc KNSA | BlackRock Inc. BLK | 4,192,446 10.500% | 1,011,858 (+31.81%) | View |
| 2024-02-14 4:39 pm Purchase | 13G | Kiniksa Pharmaceuticals International plc KNSA | HHLR ADVISORS LTD. | 3,879,426 9.900% | 338,125 (+9.55%) | View |
| 2024-02-14 3:46 pm Purchase | 13G | Kiniksa Pharmaceuticals International plc KNSA | Fairmount Funds Management LLC | 2,883,221 8.100% | 740,169 (+34.54%) | View |
| 2024-02-13 5:07 pm Sale | 13G | Kiniksa Pharmaceuticals International plc KNSA | VANGUARD GROUP INC | 2,965,299 8.370% | -261,592 (-8.11%) | View |
| 2024-02-12 06:06 am Purchase | 13G | Kiniksa Pharmaceuticals International plc KNSA | Rubric Capital Management LP | 2,907,501 8.210% | 2,907,501 (New Position) | View |
| 2024-01-25 1:48 pm Sale | 13G | Kiniksa Pharmaceuticals International plc KNSA | BlackRock Inc. BLK | 3,180,588 9.000% | -247,153 (-7.21%) | View |
| 2023-08-18 4:32 pm Purchase | 13G | Kiniksa Pharmaceuticals International plc KNSA | HHLR ADVISORS LTD. | 3,541,301 9.900% | 917,377 (+34.96%) | View |
| 2023-08-10 4:15 pm Purchase | 13G | Kiniksa Pharmaceuticals International plc KNSA | Fairmount Funds Management LLC | 2,143,052 6.100% | 2,143,052 (New Position) | View |
| 2023-03-08 2:15 pm Sale | 13G | Kiniksa Pharmaceuticals International plc KNSA | BlackRock Inc. BLK | 3,427,741 4.900% | -153,938 (-4.30%) | View |
| 2023-02-14 4:08 pm Sale | 13G | Kiniksa Pharmaceuticals International plc KNSA | HHLR ADVISORS LTD. | 2,623,924 7.600% | -296,099 (-10.14%) | View |
| 2023-02-09 11:25 am Purchase | 13G | Kiniksa Pharmaceuticals International plc KNSA | VANGUARD GROUP INC | 3,226,891 9.340% | 336,183 (+11.63%) | View |
| 2023-02-03 11:51 am Sale | 13G | Kiniksa Pharmaceuticals International plc KNSA | PICTET ASSET MANAGEMENT SA | 1,234,193 3.570% | -2,314,456 (-65.22%) | View |
| 2023-02-01 4:54 pm Purchase | 13G | Kiniksa Pharmaceuticals International plc KNSA | BlackRock Inc. BLK | 3,581,679 5.200% | 15,697 (+0.44%) | View |
| 2022-09-08 1:43 pm Purchase | 13G | Kiniksa Pharmaceuticals International plc KNSA | BlackRock Inc. BLK | 3,565,982 5.100% | 82,130 (+2.36%) | View |